Additional file 1: of Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1 release_s2jepd4hofc4tetia6hdp5b3gm

by M. Peterschmitt, Selena Freisens, Lisa Underhill, Meredith Foster, Grace Lewis, Sebastiaan Gaemers

Published by Figshare.



Table S1. Adverse events causing study discontinuation. Table S2. Cardiac adverse events reported by at least 2 patients in the pooled adverse events analysis (0.5% or more of total trials population). Table S3. Serious cardiac events. (PDF 127 kb)
In text/plain format

Archived Files and Locations

application/pdf  130.5 kB
file_4lr55576ujcpbbz6emk6dcrcwe (web) (webarchive)
Read Archived PDF
Preserved and Accessible
Type  stub
Stage   published
Date   2019-06-08
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 86d35ba4-e64f-4cfb-8bfc-74a327fd9c2d